Benchmark raised the firm’s price target on Healthcare Services (HCSG) to $30 from $28 and keeps a Buy rating on the shares. Q4 earnings upside was entirely a function of better margin realization on in-line revenue, says the analyst, who adds that contract timing points to accelerating revenue growth in the second half of 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCSG:
